We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+5%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$40.3B
AUM Growth
+$535M
(+1.3%)
Cap. Flow
-$468M
Cap. Flow
% of AUM
-1.16%
Top 10 Holdings %
Top 10 Hldgs %
15.78%
Holding
2,279
New
170
Increased
711
Reduced
1,071
Closed
189
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$178M |
| 2 |
LyondellBasell Industries
LYB
|
+$133M |
| 3 |
AT&T
T
|
+$124M |
| 4 |
Stanley Black & Decker
SWK
|
+$101M |
| 5 |
Pfizer
PFE
|
+$93.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Clorox
CLX
|
+$229M |
| 2 |
Gilead Sciences
GILD
|
+$164M |
| 3 |
Broadcom
AVGO
|
+$149M |
| 4 |
KeyCorp
KEY
|
+$145M |
| 5 |
Darden Restaurants
DRI
|
+$125M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.22% |
| 2 | Technology | 14.47% |
| 3 | Financials | 10.84% |
| 4 | Industrials | 9.01% |
| 5 | Consumer Discretionary | 8.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
551
Arch Capital
ACGL
$33.1B
| $9.52M | 0.02% |
127,216
+52,030
| +69% | +$3.76M |
|
552
Synaptics
SYNA
$3.81B
| $9.35M | 0.02% |
109,556
+79,954
| +270% | +$6.94M |
|
553
Sprouts Farmers Market
SFM
$6.85B
| $9.35M | 0.02% |
254,576
-37,794
| -13% | -$1.32M |
|
|
FOCL
554
EDAP TMS S.A.
FOCL
$187M
| $9.33M | 0.02% |
1,012,069
+606,669
| +150% | +$6.21M |
|
555
Applovin
APP
$111B
| $9.33M | 0.02% |
362,534
-72,446
| -17% | -$1.5M |
|
556
Portland General Electric
POR
$5.58B
| $9.3M | 0.02% |
198,596
-40,006
| -17% | -$1.98M |
|
557
Upbound Group
UPBD
$1.03B
| $9.29M | 0.02% |
298,305
-8,579
| -3% | -$251K |
|
558
SPX Corp
SPXC
$8.93B
| $9.21M | 0.02% |
108,372
-64,087
| -37% | -$4.77M |
|
559
Intrepid Potash
IPI
$520M
| $9.2M | 0.02% |
405,590
+129,189
| +47% | +$2.92M |
|
560
Neurocrine Biosciences
NBIX
$15.2B
| $9.19M | 0.02% |
97,447
+16,986
| +21% | +$1.66M |
|
|
MCW
561
DELISTED
Mister Car Wash
MCW
| $9.17M | 0.02% |
950,000
| – | – |
|
562
Takeda Pharmaceutical
TAK
$59.7B
| $9.14M | 0.02% |
581,862
-19,767
| -3% | -$324K |
|
563
Tenaris
TS
$28.6B
| $9.12M | 0.02% |
304,673
| – | – |
|
564
RxSight
RXST
$234M
| $9.08M | 0.02% |
+315,414
| New | +$7.02M |
|
565
Union Pacific
UNP
$169B
| $9.05M | 0.02% |
44,248
-77,992
| -64% | -$15.5M |
|
|
RSVR
566
Reservoir Media
RSVR
$616M
| $9.03M | 0.02% |
1,500,000
| – | – |
|
567
Franklin Covey
FC
$203M
| $9M | 0.02% |
206,017
-19,090
| -8% | -$707K |
|
568
Steel Dynamics
STLD
$34.3B
| $8.97M | 0.02% |
82,367
-153
| -0.2% | -$15.6K |
|
569
LivaNova
LIVN
$4.38B
| $8.94M | 0.02% |
173,830
+79,870
| +85% | +$3.75M |
|
570
Global Payments
GPN
$23.5B
| $8.92M | 0.02% |
90,540
+1,304
| +1% | +$134K |
|
|
CNR
571
Core Natural Resources Inc
CNR
$4.69B
| $8.86M | 0.02% |
130,658
-28,868
| -18% | -$1.76M |
|
572
JELD-WEN Holding
JELD
$178M
| $8.8M | 0.02% |
501,724
-2,332
| -0.5% | -$32.5K |
|
573
Cboe Global Markets
CBOE
$28.2B
| $8.79M | 0.02% |
63,679
-1,882
| -3% | -$257K |
|
574
Albertsons Companies
ACI
$6.23B
| $8.78M | 0.02% |
402,592
-11,450
| -3% | -$238K |
|
|
ARIS
575
DELISTED
Aris Water Solutions
ARIS
| $8.76M | 0.02% |
848,836
-94,773
| -10% | -$819K |
|
Similar funds
Federated Hermes's Q2 2023 Portfolio in Review
As of Q2 2023, Federated Hermes held 2,279 positions worth $40.3B, up 1.3% from $39.7B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Federated Hermes's Q2 2023 filing shows 170 new, 711 increased, 1,071 reduced and 189 closed positions. Its largest new stake was HashiCorp, Inc. Class A Common Stock: 1,317,400 shares worth $34.5M. The largest sale was Clorox, an estimated $229M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 20% a quarter earlier, followed by Technology and Financials.
- Federated Hermes's largest Q2 2023 buy was HashiCorp, Inc. Class A Common Stock: 1,317,400 shares worth $34.5M.
- Federated Hermes added most to Amgen in Q2 2023, an estimated $178M increase.
- Federated Hermes's biggest Q2 2023 reduction was Clorox, cutting an estimated $229M.
- Federated Hermes fully exited Prometheus Biosciences, Inc. Common Stock in Q2 2023, selling an estimated $55.4M.
- Federated Hermes's ten largest holdings make up 16% of its $40.3B portfolio in Q2 2023.
- Federated Hermes opened 170 new positions and closed 189 in Q2 2023.
- Federated Hermes's portfolio value rose 1.3% quarter-over-quarter to $40.3B.
Based on Federated Hermes's 13F filing for Q2 2023, filed 14 Aug 2023.